Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-50553
Biomedicines 2022 Jan 08;101:. doi: 10.3390/biomedicines10010134.
Show Gene links Show Anatomy links

Chlorin Endogenous to the North Pacific Brittle Star Ophiura sarsii for Photodynamic Therapy Applications in Breast Cancer and Glioblastoma Models.

Klimenko A , Rodina EE , Silachev D , Begun M , Babenko VA , Benditkis AS , Kozlov AS , Krasnovsky AA , Khotimchenko YS , Katanaev VL .


Abstract
Photodynamic therapy (PDT) represents a powerful avenue for anticancer treatment. PDT relies on the use of photosensitizers-compounds accumulating in the tumor and converted from benign to cytotoxic upon targeted photoactivation. We here describe (3S,4S)-14-Ethyl-9-(hydroxymethyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid (ETPA) as a major metabolite of the North Pacific brittle stars Ophiura sarsii. As a chlorin, ETPA efficiently produces singlet oxygen upon red-light photoactivation and exerts powerful sub-micromolar phototoxicity against a panel of cancer cell lines in vitro. In a mouse model of glioblastoma, intravenous ETPA injection combined with targeted red laser irradiation induced strong necrotic ablation of the brain tumor. Along with the straightforward ETPA purification protocol and abundance of O. sarsii, these studies pave the way for the development of ETPA as a novel natural product-based photodynamic therapeutic.

PubMed ID: 35052813
PMC ID: PMC8773836
Article link: Biomedicines




Article Images: [+] show captions
References [+] :
Akimoto, Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas. 2012, Pubmed